{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:06:55Z","timestamp":1793740015576,"version":"4.6.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ijantimicag.2022.106598","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T05:04:53Z","timestamp":1651813493000},"page":"106598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Short- versus standard-course intravenous antibiotics for peri-prosthetic joint infections managed with debridement and implant retention: a randomised pilot trial using a desirability of outcome ranking (DOOR) endpoint"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4334-5351","authenticated-orcid":false,"given":"Laurens","family":"Manning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Metcalf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4881-2860","authenticated-orcid":false,"given":"Michael","family":"Dymock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7563-6180","authenticated-orcid":false,"given":"Owen","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjy","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piers","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Loewenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dewar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Huggan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua S","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijantimicag.2022.106598_bib0001","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJMcp0905029","article-title":"Clinical practice. Infection associated with prosthetic joints","volume":"361","author":"Del Pozo","year":"2009","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ijantimicag.2022.106598_bib0002","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1086\/605630","article-title":"Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship","volume":"49","author":"Roberts","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"8 Suppl","key":"10.1016\/j.ijantimicag.2022.106598_bib0003","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.arth.2012.02.022","article-title":"Economic burden of periprosthetic joint infection in the United States","volume":"27","author":"Kurtz","year":"2012","journal-title":"J Arthroplasty"},{"issue":"5","key":"10.1016\/j.ijantimicag.2022.106598_bib0004","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/ans.15774","article-title":"High prevalence of older Australians with one or more joint replacements: estimating the population at risk for late complications of arthroplasty","volume":"90","author":"Manning","year":"2020","journal-title":"ANZ J Surg"},{"issue":"5","key":"10.1016\/j.ijantimicag.2022.106598_bib0005","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa068","article-title":"Clinical characteristics, etiology, and initial management strategy of newly diagnosed periprosthetic joint infection: A multicenter, prospective observational cohort study of 783 patients","volume":"7","author":"Manning","year":"2020","journal-title":"Open Forum Infectious Diseases"},{"issue":"6","key":"10.1016\/j.ijantimicag.2022.106598_bib0006","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jinf.2018.08.017","article-title":"Debridement, antibiotics and implant retention for periprosthetic joint infections: A systematic review and meta-analysis of treatment outcomes","volume":"77","author":"Kunutsor","year":"2018","journal-title":"J Infect"},{"issue":"2S","key":"10.1016\/j.ijantimicag.2022.106598_bib0007","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.arth.2018.09.038","article-title":"Introduction: Proceedings of International Consensus on Orthopedic Infections","volume":"34","author":"Parvizi","year":"2019","journal-title":"J Arthroplasty"},{"issue":"11","key":"10.1016\/j.ijantimicag.2022.106598_bib0008","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1302\/0301-620X.99B11.BJJ-2017-0088.R1","article-title":"Outcomes following debridement, antibiotics and implant retention in the management of periprosthetic infections of the hip: a review of cohort studies","volume":"99-B","author":"Tsang","year":"2017","journal-title":"Bone Joint J"},{"issue":"1","key":"10.1016\/j.ijantimicag.2022.106598_bib0009","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ijantimicag.2022.106598_bib0010","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1302\/0301-620X.95B11.33135","article-title":"Proceedings of the International Consensus on Periprosthetic Joint Infection","volume":"95-B","author":"Parvizi","year":"2013","journal-title":"Bone Joint J"},{"issue":"19","key":"10.1016\/j.ijantimicag.2022.106598_bib0011","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","article-title":"for the Foreign-Body Infection Study Group. Role of rifampin for treatment of orthopedic implant-related Staphylococcal infections: A randomized controlled trial","volume":"279","author":"Zimmerli","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ijantimicag.2022.106598_bib0012","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijantimicag.2016.05.021","article-title":"Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial","volume":"48","author":"Lora-Tamayo","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1016\/j.ijantimicag.2022.106598_bib0013","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"Li","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ijantimicag.2022.106598_bib0014","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5694\/mja12.11703","article-title":"Steering Group of the Australasian Society for Infectious Diseases Clinical Research N. Determining research priorities for clinician-initiated trials in infectious diseases","volume":"198","author":"Paterson","year":"2013","journal-title":"Med J Aust"},{"issue":"5","key":"10.1016\/j.ijantimicag.2022.106598_bib0015","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/cid\/civ495","article-title":"Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)","volume":"61","author":"Evans","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106598_bib0016","series-title":"Therapeutic guidelines: Antibiotics","year":"2019"},{"key":"10.1016\/j.ijantimicag.2022.106598_bib0017","series-title":"R: A Language and Environment for Statistical Computing","year":"2012"},{"issue":"2","key":"10.1016\/j.ijantimicag.2022.106598_bib0018","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"10","key":"10.1016\/j.ijantimicag.2022.106598_bib0019","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/cid\/ciy766","article-title":"Good studies evaluate the disease while great studies evaluate the patient: Development and application of a desirability of outcome ranking endpoint for Staphylococcus aureus bloodstream infection","volume":"68","author":"Doernberg","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijantimicag.2022.106598_bib0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s40121-021-00401-1","article-title":"Using an ordinal approach to compare outcomes between vancomycin versus ceftaroline or daptomycin in MRSA bloodstream infection","volume":"10","author":"Barlow","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"2","key":"10.1016\/j.ijantimicag.2022.106598_bib0021","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/cid\/cix783","article-title":"Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae","volume":"66","author":"van Duin","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ijantimicag.2022.106598_bib0022","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5301\/jva.5000670","article-title":"Peripherally inserted central catheter-related complications in cancer patients: a prospective study of over 50,000 catheter days","volume":"18","author":"Kang","year":"2017","journal-title":"J Vasc Access"},{"issue":"4","key":"10.1016\/j.ijantimicag.2022.106598_bib0023","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5301\/jva.5000389","article-title":"Evaluation of PICC complications in orthopedic inpatients with bone infection for long-term intravenous antibiotics therapy","volume":"16","author":"Valbousquet Schneider","year":"2015","journal-title":"J Vasc Access"},{"issue":"8","key":"10.1016\/j.ijantimicag.2022.106598_bib0024","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/j.1538-7836.2008.03053.x","article-title":"Randomized controlled trial of peripherally inserted central catheters vs. peripheral catheters for middle duration in-hospital intravenous therapy","volume":"6","author":"Periard","year":"2008","journal-title":"J Thromb Haemost"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857922001078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857922001078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:43:23Z","timestamp":1760377403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857922001078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0924857922001078"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106598","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short- versus standard-course intravenous antibiotics for peri-prosthetic joint infections managed with debridement and implant retention: a randomised pilot trial using a desirability of outcome ranking (DOOR) endpoint","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106598"}}